Insiders · Profile

Greenstreet Yvonne

Chief Executive Officer at ALNYLAM PHARMACEUTICALS. Filing since 26 Mar 2018. CIK 0001446125

Company

Date

Role

Action

Shares

Amount

Of holding

ALNY ALNYLAM PHARMACEUTICALS, INC.

4 Mar 2026

Chief Executive Officer

Sold at will

2,933

$947.58K

3.0%

ALNY ALNYLAM PHARMACEUTICALS, INC.

2 Mar 2026

Chief Executive Officer

Sold at will

6,799

$2.23M

6.4%

ALNY ALNYLAM PHARMACEUTICALS, INC.

13 Feb 2026

Chief Executive Officer

Sold at will

6,958

$2.16M

7.5%

ALNY ALNYLAM PHARMACEUTICALS, INC.

12 Jan 2026

Chief Executive Officer

Sold at will

9,577

$3.48M

10.9%

ALNY ALNYLAM PHARMACEUTICALS, INC.

13 Nov 2025

Chief Executive Officer

Sold on a plan

10,000

$4.51M

13.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

12 Nov 2025

Chief Executive Officer

Sold on a plan

15,650

$7.10M

19.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

2 Oct 2025

Chief Executive Officer

Sold at will

8,924

$4.03M

12.0%

ALNY ALNYLAM PHARMACEUTICALS, INC.

18 Aug 2025

Chief Executive Officer

Sold at will

6,979

$3.16M

11.0%

ALNY ALNYLAM PHARMACEUTICALS, INC.

2 Jun 2025

Chief Executive Officer

Sold on a plan

19,297

$5.90M

28.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

30 May 2025

Chief Executive Officer

Sold on a plan

31,640

$9.63M

39.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

3 Mar 2025

Chief Executive Officer

Sold at will

3,877

$945.16K

3.8%

ALNY ALNYLAM PHARMACEUTICALS, INC.

28 Feb 2025

Chief Executive Officer

Sold at will

2,900

$700.89K

3.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

14 Feb 2025

Chief Executive Officer

Sold at will

1,213

$309.53K

1.5%

ALNY ALNYLAM PHARMACEUTICALS, INC.

26 Nov 2024

Chief Executive Officer

Sold at will

5,219

$1.31M

6.2%

ALNY ALNYLAM PHARMACEUTICALS, INC.

20 Aug 2024

Chief Executive Officer

Sold on a plan

15,000

$4.20M

17.0%

ALNY ALNYLAM PHARMACEUTICALS, INC.

1 Aug 2024

Chief Executive Officer

Sold on a plan

15,148

$4.09M

17.1%

ALNY ALNYLAM PHARMACEUTICALS, INC.

11 Jul 2024

Chief Executive Officer

Sold on a plan

7,093

$1.85M

8.8%

ALNY ALNYLAM PHARMACEUTICALS, INC.

25 Jun 2024

Chief Executive Officer

Sold at will

8,301

$1.92M

9.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

28 Feb 2024

Chief Executive Officer

Sold at will

2,932

$455.36K

5.7%

ALNY ALNYLAM PHARMACEUTICALS, INC.

16 Feb 2024

Chief Executive Officer

Sold at will

7,030

$1.04M

13.5%

ALNY ALNYLAM PHARMACEUTICALS, INC.

4 Aug 2023

Chief Executive Officer

Sold at will

4,057

$753.99K

10.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

27 Apr 2023

Chief Executive Officer

Sold at will

7,615

$1.48M

20.1%

ALNY ALNYLAM PHARMACEUTICALS, INC.

6 Aug 2021

President & COO

Sold, plan not stated

53,064

$10.56M

82.8%

ALNY ALNYLAM PHARMACEUTICALS, INC.

12 Jan 2021

President & COO

Sold, plan not stated

3,125

$503.13K

39.3%

ALNY ALNYLAM PHARMACEUTICALS, INC.

10 Jul 2020

Chief Operating Officer

Sold, plan not stated

46,639

$7.51M

90.6%

ALNY ALNYLAM PHARMACEUTICALS, INC.

9 Jul 2020

Chief Operating Officer

Sold, plan not stated

11,236

$1.81M

70.0%

ALNY ALNYLAM PHARMACEUTICALS, INC.

6 May 2020

Chief Operating Officer

Sold, plan not stated

50,000

$7.50M

91.2%

ALNY ALNYLAM PHARMACEUTICALS, INC.

5 May 2020

Chief Operating Officer

Sold, plan not stated

7,811

$1.09M

61.8%

ALNY ALNYLAM PHARMACEUTICALS, INC.

10 Feb 2020

Chief Operating Officer

Sold, plan not stated

9,892

$1.29M

83.8%

ALNY ALNYLAM PHARMACEUTICALS, INC.

7 Feb 2020

Chief Operating Officer

Sold, plan not stated

6,250

$774.38K

50.2%

ALNY ALNYLAM PHARMACEUTICALS, INC.

20 Nov 2019

Chief Operating Officer

Sold, plan not stated

8,404

$882.42K

81.4%

ALNY ALNYLAM PHARMACEUTICALS, INC.

30 Aug 2018

EVP, Chief Operating Officer

Sold, plan not stated

2,500

$300.00K

56.6%

ALNY ALNYLAM PHARMACEUTICALS, INC.

26 Mar 2018

EVP, Chief Operating Officer

Sold, plan not stated

7,221

$985.96K

100%

33 decisions on file.